SHANNON SPARKS: Open Payments
NPI 1730426024 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 42 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $978
Food & beverage: $870Education: $109
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Genmab U.S., Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Janssen Biotech, Inc. | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Daiichi Sankyo Inc. | 3 | $64 |
| PFIZER INC. | 2 | $50 |
| Eisai Inc. | 2 | $46 |
| TerSera Therapeutics LLC | 1 | $36 |
Products named: Enhertu, KEYTRUDA, IBRANCE, SCEMBLIX, DARZALEX, Lenvima, Epkinly, Xermelo.
Industry payments across NC — which companies pay providers there.
